Curie.Bio (II)

About Curie.Bio (II)

Curie.Bio (II) is a venture capital firm based in United States, focusing on Seed stage investments. The fund actively supports founders building innovative solutions in Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionUnited States

Funding StageSeed

Industry Focus

Deep Tech

Saas

Investor Signals Profile

active

Sweet Spot

Early biotech founders building RNA or drug discovery platforms

biotech

RNA therapeutics

drug discovery

CNS

early-stage

Bullish Signals

Operator CXOs embedded with foundersexternal

RNA therapeutics across multiple modalitiesexternal

CXO guides discovery through clinical stagelinkedin

27K+ LinkedIn followers — strong brandlinkedin

Contrarian Signals

Highly specialized — narrow biotech focusexternal

Founder Do's

Bring deep scientific domain expertise

Focus on translational development readiness

Engage with CXO network early

Leverage CXO for clinical positioning strategy

Tap CNS program experience from discovery to clinic

Founder Don'ts

Skip clinical positioning strategy

Underestimate RNA modality complexity

Bypass CXO involvement in early discovery

Key GPs & Partners

Aimee Jackson

CXO

RNA therapeuticsoperatordrug discovery

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size$340M

Saves0

Website

Key People

Zach Weinberg, Alexis Borisy

Aimee JacksonCXO